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Abstract: 
 
 One-pot multistep stereoselective cascade reactions were implemented for the straightforward synthesis 
of various nitrocyclitols. Two kinases, an aldolase and a phosphatase were involved in this process together with 
a spontaneous intramolecular Henry reaction to provide a nitrocyclitol moiety. The C-C bond formation 
catalyzed by the aldolase and the nitroaldol reaction were key steps to build the carbocycle stereoselectively. The 
acceptor substrates for aldolases were all 4-nitrobutanal structurally based, hydroxylated or not on C2 and/or C3 
positions. On the one side, L-fuculose-1-phosphate aldolase (FucA) has catalyzed the formation of the expected 
(R,R; D-erythro) aldol except in the case of 4-nitrobutanal from which (R,S; L-threo) aldol was also present. On 
the other side, L-rhamnulose-1-phosphate aldolase has always provided the expected (R,S; L-threo) aldol 
together with minor amount of (R,R; D-erythro) aldol thus being less stereoselective than FucA. The 
intramolecular Henry reaction has occurred spontaneously on the aldol due to the presence of both ketone and 
terminally positioned nitro group. This cyclisation was stereoselective and correlated to the presence or not of a 
hydroxyl group in β to the nitro group. From 4-nitrobutanal as substrate and for one defined stereochemistry by 
the aldolase (R,R or R,S) one cyclitol was formed. In the other cases, two diastereomeric series were formed due 
to the presence of an R and S configured alcohol function in β to the nitro group. The combination of this set of 
reactions successfully furnished 11 nitrocyclitols never described before in literature. 
 
1. Introduction 
 
The high stereoselectivity of aldolases in C-C bond formation gives them tremendous synthetic applications as 
biocatalysts. Among the different families of aldolases, dihydroxyacetone phosphate (DHAP)-dependent 
aldolases are particularly attractive since two new stereocentres are made during the formation of the new C-C 
bond between two carbonyl compounds. Thus a set of four possible diastereoisomers of keto vicinal diols can be 
prepared.[1-5] Among them L-fuculose-1-phosphate and L-rhamnulose-1-phosphate aldolases (FucA and RhuA 
both from Escherichia coli) providing respectively (R,R) and (R,S) configurations were recently and efficiently 
used for the synthesis of iminosugars. These wild-type or variant (FucAF131A) aldolases have shown a broad 
tolerance towards acceptor substrates, even accepting in some cases sterically constrained aldehydes.[6-8] The 
strict requirement for the donor substrate DHAP, a rather expensive and unstable compound has led to the 
development of various strategies for its synthesis. Thus, well documented chemical or enzymatic DHAP 
preparations are accessible[9] and have facilitated the use of DHAP-dependent aldolases in organic synthesis. 
Enzymatic preparations are of particular interest as they can be combined in cascade reactions with other 
enzymes to provide highly functionalized molecules.[10] A preferred choice, however not applicable in all cases, 
is the direct use of dihydroxyacetone (DHA) as donor due to its low cost and easy availability. Wild-type RhuA 
from E. coli can accept the unphosphorylated donor with a low activity that could be increased in the presence of 
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borate buffer.[11] FucA had no detectable activity with DHA even in the presence of borate.[12, 13] A RhuA 
variant was recently built in order to improve this promiscuous catalytic property.[14]  
Nitrocyclitols belong to the large family of cyclitols (also found as carbocyclic polyols or carbasugars).[15-18] 
They are essentially found as synthetic precursors of aminocyclitols.[19, 20] However natural nitrosugars 
moieties do exist and are derived from aminosugars via an oxidation step. They are found in ~50 bioactive 
natural products.[21, 22] Cyclitols often acting as glycosidase inhibitors are of large interest as they exhibit 
antitumor, antibacterial, antifungal, antimalarial, and antiviral activities.[17, 23, 24] Consequently, there have 
been continuous efforts in the last decade to prepare natural cyclitols and aminocyclitols as well as analogues 
with enhanced or more selective biological profiles in order to study in depth the influence of this moiety on 
their specific receptors.[15-18, 25-27] 
Few years ago, we have reported that nitrocyclitols can be efficiently prepared by a one-pot multi-step 
chemoenzymatic synthesis, consisting of an aldol reaction catalyzed by an aldolase and an intramolecular 
spontaneous Henry reaction as key steps (scheme 1). On the one hand, starting from several nitrobutanals 
fructose-1,6-bisphosphate aldolase (FBA)[28-30] and fructose-6-phosphate aldolase (FSA)[20, 31] have led to 
nitroaldols with 3S,4R (becoming 2S,3R in the final cyclitol) defined configurations. On the other hand, the 
following spontaneous intramolecular Henry reaction has provided stereoselectively two main cyclitol families 
(scheme 1, A and B). These two families are correlated to the R and S configurations (“racemic”) when R2=OH 
on the aldehyde acceptor subtrate. FSA has advantageously replaced FBA, thus avoiding tedious DHAP 
preparation. In addition, as this aldolase can accept other donors than DHA, the use of hydroxyacetone (HA) as 
donor has enlarged the scope of the process with variation on R3 group. However, the nitroaldol reaction in the 
presence of the methyl group was less stereoselective.[20]  
 
 
Scheme 1: One-pot cascade reactions for the synthesis of nitrocyclitols 
 
Encouraged by these interesting results we envisaged such stereoselective cascades using RhuA and FucA as key 
biocatalysts for C-C bond formation. The overall process would lead to different stereocenters at C2 and C3 
cyclitol positions due to aldolase stereoselectivity together with two other stereocentres (C1 and C6) established 
by the nitroaldolisation. Instead of using chemically synthetized DHAP,[28] a second bi-enzymatic system 
developed by García-Junceda’s group has been coupled for in situ generation of DHAP from DHA as initial 
donor.[32] This system is based on the use of the recombinant ATP-dependent dihydroxyacetone kinase (DHAK 
from Citrobacter freundii CECT 4626).[33] The regeneration of ATP is catalyzed by acetate kinase (AK). The 
new one-pot multi-enzyme system is depicted scheme 2. 
 
2. Materials and methods 
2.1. Organisms and enzyme production. 
Acetyl phosphate, acetate kinase from E. coli (E.C.2.7.2.1) and acid phosphatase from wheat germ (E.C. 3.1.3.2) 
were purchased from Sigma-Aldrich Company. 
RhuA, FucA from E. coli and DHAK from C. freundii were all produced and purified by the same protocol as 
described below. 
E.coli BL21 (DE3) strains overexpressing the corresponding enzyme were grown on 5 mL of Luria-Bertani 
medium (yeast: 5 g/L, tryptone: 10 g/L and NaCl: 10 g/L), bacteriologic agar (15 g/L) and an antibiotic (0.1 
mg/mL of ampicillin for DHAK and 0.06 mg/mL of kanamycin for RhuA or FucA). Those pre-cultures were 
used to inoculate 1L of sterile Luria-Bertani medium containing the antibiotic and allowed to stir for 3h in 37°C 
till a 0.5 OD value (at 600 nm) was reached. Then 2 mL (for DHAK) or 1 mL (for the aldolases) of a 0.5M 
solution of IPTG was added and the mixture shaked overnight at 30°C. The culture was then centrifuged (8,000 
rpm) for 15 min at 4°C and the supernatant was discarded. The harvested cells were washed with buffer Tris-HCl 
50 mM pH 8 buffer and centrifuged again. Washed cells were suspended in buffer (8 mL /gram of cells), 
disrupted by ultrasonication at 4°C and centrifuged at 12,000 rpm during 30 min at 4°C. The cell-free extract 
obtained was loaded onto a Ni2+-NTA IMAC and the stationary phase was then washed with phosphate buffer 
(20 mM, pH 7.5) containing 500 mM of NaCl. The protein was gradiently eluted using the previous buffer 
containing 50-500 mM of imidazole. Positive fractions checked by the Bradford test were pooled together and 
ultrafiltrated under pressure through a 30 kDa cut-off membrane using phosphate buffer. Dialysis could also be 
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performed on small volumes. The solution was finally freeze-dried. The obtained white powder can be stored at 
4°C for months without loss of enzyme activity.  
DHAK activity assay.  
The DHAK activity was spectrophotometrically measured by enzymatic quantification of the DHAP formed in 
the phosphorylation reaction. This assay was run at room temperature following NADH absorbance at 340 nm 
(εNADH= 6220 cm-1M-1) for 15 minutes in a cuvette of 1 mL containing TRIS-HCl (800 L, 50 mM, pH 8.0), 
NADH (10 L, 20 mM, 0.2 mol), ATP (75 L, 50 mM, 3.75 mol), MgSO4 (100 L, 50 mM, 5 mol), GPDH 
(2 L, 630 U/ml, 1.3 U), TPI (2 L, 6300 U/ml, 12.6 U), DHAK (1-2 L of purification aliquot, 2.5-5.0 g of 
protein), and DHA (2,5 L, 1 M, 2.5 mol). One unit was defined as the amount of kinase that catalyzes the 
phosphorylation of 1µmol of DHA in one min. 
 
RhuA and FucA activity assays.  
One unit was defined as the amount of the enzymes able to retroaldolize 1µmol/min of L-fuculose-1-phosphate 
or L-rhamnulose-1-phosphate respectively producing dihydroxyacetone phosphate (DHAP).[34] Accumulated 
DHAP from retroaldol reaction was detected and quantified using the GPDH/TPI spectrophotometric assay 
previously described. The enzymatic assays were run at room temperature following the decrease of absorbance 
at 340 nm for 20 minutes in a cuvette of 1 mL containing Tris-HCl buffer (800 L, 50 mM, pH 8.0), NADH (10 
L, 20 mM, 0.2 mol), GPDH (2 L, 630 U/ml, 1.3 U), TPI (2 L, 6300 U/ml, 12.6 U), RhuA (1.0-2.5 L of 
purification aliquot, 0.05-0.13 mg of protein) or FucA (1.0-2.5 L of purification aliquot, 0.05-0.17 mg of 
protein), ZnCl2 (1 L, 10 mM, 0.01 mol), and the corresponding substrate (2.5 L, 50 mM, 1.25 mol). 
Alternatively a rapid activity assay is described in this work. Aldolization between DHAP and 
dimethoxacetaldehyde (DMA) is spectrophotometrically monitored following the DHAP consumption by GPDH 
reaction. In this case, one unit was defined as the ability of the enzymes to aldolize 1µmol/min of 
dimethoxacetaldehyde and DHAP producing the corresponding aldol.  
 
2.2. Substrates syntheses and domino reactions. 
Modified procedure for preparation of 4-nitrobutanal 1 
To a solution of freshly distilled acrolein (4 mL, 60 mmol, 1 eq.) in 290 mL of water were added nitromethane 
(32.2 mL, 600 mmol, 10 eq.) and bovin serum albumin (1 g). The reaction mixture was allowed to gentle stir at 
room temperature for 7 hours. Ethanol 95% was added and the mixture was filtered through a pad of celite. After 
concentration under vacuum the solution was bulb-to-bulb distilled under reduced pressure to afford compound 1 
in 37% yield displaying same spectral characteristics than already mentioned.[29] 
 
General procedure for preparation of nitrocyclitols with FucA and RhuA (one-pot – two-steps procedure): 
a) Preparation of DHAP:[35] 
To distilled water (2.7 mL), were successively added solutions of DHA (150 L, 1M, 0.3 mmol, 1 eq.), MgSO4 
(150 l, 0.5M, 0.075 mmol), acetylphosphate (1.2 mL, 0.5M, 0.6 mmol, 2 eq.) and phosphate buffer (1.5 mL, 60 
mM, 1.5 mL, pH 7). The pH was adjusted to 7.5 and a solution of DHAK (160 L, 36 U/mL, 6 U), AK (100 L, 
170 U/mL, 18 U) and ATP (40 L, 0.5M, 9.8 mol) were added. The total phosphorylation of DHA was 
spectrophotometrically measured by GPDH enzymatic quantification of DHAP. This spectrophotometric assay 
was run at room temperature during 10 min in a final volume of 1 mL, containing Tris-HCl 50 mM  pH 8 (975 
L), NADH (20 L), aliquot of the reaction (2.5-5.0 L), and a mixture of GPDH/TPI (2 L). 
b) Synthesis of nitrocyclitols: 
To the freshly prepared DHAP solution, aldehyde (450 mol, 1.5 eq.) was added to the solution along with a 
solution of ZnCl2 (10 L, 10 mM) and DMSO (900 L, for water insoluble aldehyde, otherwise DMSO was 
replaced by water). The reaction was then started by aldolase (FucA or RhuA, 200 L, 43 U/mL = 9 U) addition 
and the reaction was shaken until total disappearance of DHAP (DHAP spectrophotometric assay). Then, the pH 
was lowered to 3.9 and the solution was centrifuged (20,000 rpm, 40 min, 5°C) to recover the supernatant. To 
this last solution, acid phosphatase (18 mg, 20 U) was added and the mixture was shaken for 24 h. The solution 
was centrifuged (20,000 rpm, 40 min, 5°C) and the supernatant was concentrated under reduced pressure at 
30°C. The residue was purified by flash chromatography (CH2Cl2/MeOH 9:1) to afford the desired nitrocyclitols; 
RhuA: 2 (192 mg,77 %), 3 (11 mg, 4 %), 5 (314 mg, 67 %), 6 (61 mg, 13 %), 9 (266 mg, 62 %), 10 (73 mg, 17 
%), 13 (98 mg, 41 %), 14 (98 mg, 41 %), FucA: 2 (164 mg, 66 %), 3 (42 mg 17 %), 6 (271 mg, 58 %), 7 (112 
mg, 24 %), 10 (167 mg, 39 %), 11 (189 mg, 44 %), 14 (95 mg, 44 %), 15 (81 mg, 34 %). 
 
(1R,2R,3S,6S)-1-Hydroxymethyl-6-nitrocyclohexane-1,2,3-triol 2: Rf = 0.60 (DCM/MeOH 9:1). IR: ν = 3367, 
2495, 1553 cm-1.   25D – 20 (c = 1, CH3OH). (2 is the enantiomer of the already described nitrocyclitol obtained 
with FBA[29]) 
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(1S,2R,3R,6R)-1-Hydroxymethyl-6-nitrocyclohexane-1,2,3-triol 3: Rf = 0.65 (DCM/MeOH 9:1). IR: ν = 3367, 
2495, 1553 cm-1.   25D + 18 (c = 1, CH3OH). 1H NMR (400 MHz, MeOD): δ = 4.75 (dd, J = 12.4, 4.0 Hz, 1H, 
6ax-H), 4.00 (m, 1H, 3ax-H), 3.88 (d, J = 2.6 Hz, 1H, 2eq-H), 3.83 (d, J = 11.5 Hz, 1H, 7-H), 3.55 (d, J = 11.5 
Hz, 1H, 7-H), 2.41 (m, 1H, 5eq-H), 1.93 (m, 2H, 5ax-H, 4eq-H), 1.76 (m, 1H, 4ax-H) ppm.13C NMR (100 MHz, 
MeOD): δ = 87.8 (6-C), 76.6 (1-C), 74.8 (2-C), 71.3 (3-C), 65.1 (7-C), 25.8 (4-C), 25.7 (5-C) ppm. IR: ν = 3367, 
2495, 1553 cm-1, 1047 (CO) cm-1. HRMS (ES+): m/z calcd. for C7H13NO6+Na+: 230.0641 [M+Na+], found 
230.0632. 
 
(1R,2R,3S,5R,6S)-1-Hydroxymethyl-6-nitrocyclohexane-1,2,3,5-tetraol 5: IR: ν = 3481, 1545, 1378, 1064 cm-1.
  25D – 26 (c = 1, CH3OH). (5 is the enantiomer of the already described nitrocyclitol obtained with FBA[30]) 
 
(1S,2R,3R,5S,6R)-1-Hydroxymethyl-6-nitrocyclohexane-1,2,3,5-tetraol 6: IR: ν = 3357, 1554, 1375, 1053 cm-1.
  25D + 22 (c = 1, CH3OH). 1H NMR (400 MHz, MeOD): δ = 4.55 (d, J = 10.2 Hz, 1H, 6ax-H), 4.43 (ddd, J = 
10.2,10.8,4.2 Hz, 1H, 5ax-H), 4.06 (m, 1H, 3ax-H), 3.82 (d, J = 2.4 Hz, 1H, 2eq-H), 3.79 (d, J = 11.3 Hz, 1H, 7-
H), 3.50 (d, J =11.3 Hz, 1H, 7-H), 2.02 (m, 1H, 4eq-H), 1.82 (ddd, J = 11.9,11.9,10.8 Hz, 1H, 4ax-H) ppm.13C 
NMR (100 MHz, MeOD): δ = 93.2 (6-C), 76.4 (1-C), 73.5 (2-C), 67.4 (5-C), 66.9 (3-C), 65.7 (7-C), 36.4 (4-C) 
ppm. HRMS (ES+): m/z calcd. for C7H13NO7+Na+: 246.0590 [M+Na+], found 246.0588. 
 
(1R,2R,3R,5R,6S)-1-Hydroxymethyl-6-nitrocyclohexane-1,2,3,5-tetraol 7: IR: ν = 3357, 1554, 1375, 1053 cm-1.
  25D – 29 (c = 1, CH3OH). 1H NMR (400 MHz, MeOD): δ = 4.75 (ddd, J = 10.6,10.8,4.6 Hz, 1H, 5ax-H), 4.70 
(d, J = 10.6 Hz, 1H, 6ax-H), 4.15 (m, 1H, 3eq-H), 3.76 (d, J =12.4 Hz, 1H, 7-H), 3.65 (d, J = 2.2 Hz, 1H, 2ax-
H), 3.17 (d, J = 12.4 Hz, 1H, 7-H), 2.26 (m, 1H, 4eq-H), 1.52 (ddd, J = 12.1,12.1,10.8 Hz, 1H, 4ax-H) ppm.13C 
NMR (100 MHz, MeOD): δ = 93.4 (6-C), 79.1 (1-C), 72.2 (3-C), 69.0 (2-C), 64.6 (5-C), 61.8 (7-C), 38.1 (4-C) 
ppm. HRMS (ES+): m/z calcd. for C7H13NO7+Na+: 246.0590 [M+Na+], found 246.0586. 
 
(1R,2R,3S,4R,5S,6S)-1-hydroxymethyl-6-nitrocyclohexane-1,2,3,4,5-pentol 9: IR: ν = 3418, 1556, 1378, 1109 
cm-1   25D –10 (c = 1.0, CH3OH). (9 is the enantiomer of the already described nitrocyclitol obtained with FBA 
or FSA).[28] 
 
On the mixture of 1-hydroxymethyl-6-nitrocyclohexane-1,2,3,4,5-pentol 10 and 11 obtained with FucA as 
catalyst: HRMS (ES+): m/z calcd. for C7H13NO8+Na+: 262.0539 [M+Na+], found 262.0551.  
 
(1S,2R,3R,4R,5R,6R)-1-hydroxymethyl-6-nitrocyclohexane-1,2,3,4,5-pentol 10: IR: ν = 3418, 1556, 1378, 1109 
cm-1.   25D +21 (c = 1.0, CH3OH). 1H NMR (400 MHz, MeOD): δ = 4.71 (d, J = 10.8 Hz, 1H, 6ax-H), 4.47 (dd, 
J = 10.8, 3.1 Hz, 1H, 5ax-H), 4.15 (m, 1H, 4eq-H), 4.06 (dd, J = 3.1, 3.3 Hz, 1H, 3ax-H), 3.99 (d, J = 3.3 Hz, 
1H, 2eq-H), 3.76 (d, J = 11.0 Hz, 1H, 7-H), 3.20 (d, J = 11.0 Hz, 1H, 7-H) ppm. 13C NMR (100 MHz, MeOD): δ 
= 91.1 (6-C), 79.3 (1-C), 76.4 (4-C), 75.4 (2-C), 69.4 (5-C), 67.1 (3-C), 65.2 (7-C) ppm.  
 
(1R,2R,3R,4R,5S,6S)-1-hydroxymethyl-6-nitrocyclohexane-1,2,3,4,5-pentol 11: IR: ν = 3418, 1556, 1378, 1109 
cm-1   25D – 20 (c = 1.0, CH3OH). 1H NMR (400 MHz, MeOD): δ = 4.47 (d, J = 9.7 Hz, 1H, 6ax-H), 4.55 (dd, J 
= 9.7, 10.4 Hz, 1H, 5ax-H), 4.15 (m, 1H, 3eq-H), 3.85 (d, J = 11.5 Hz, 1H, H-7), 3.72 (d, J = 2.2 Hz, 1H, H-2ax-
H), 3.52 (d, J = 11.5 Hz, 1H, H-7), 3.44 (dd, J = 10.4, 2.7 Hz, 1H, 4ax-H) ppm. 13C NMR (100 MHz, MeOD): δ 
= 91.1 (6-C), 76.4 (1-C), 76.0 (4-C), 75.4 (2-C), 69.4 (5-C), 67.1 (3-C), 61.5 (7-C) ppm.  
 
(1R,2R,3S,4S,5S,6S)-1-hydroxymethyl-6-nitrocyclohexane-1,2,3,4,5-pentol 13:   25D – 13 (c = 1.0, CH3OH). 
(13 is the enantiomer of the already described nitrocyclitol obtained with FBA or FSA).[28]  
 
On the mixture of 1-hydroxymethyl-6-nitrocyclohexane-1,2,3,4,5-pentol 14 and 15 obtained with FucA as 
catalyst: HRMS (ES+): m/z calcd. for C7H13NO8+Na+: 262.0539 [M+Na+], found 262.0546.  
 
(1S,2R,3R,4S,5R,6R)-1-hydroxymethyl-6-nitrocyclohexane-1,2,3,4,5-pentol 14:   25D + 11 (c = 1.0, CH3OH). 
1H NMR (400 MHz, MeOD): δ = 4.69 (d, J = 10.6 Hz, 1H, 6ax-H), 4.47 (dd, J = 10.6, 10.6 Hz, 1H, 5ax-H), 4.03 
(dd, J = 10.1, 3.4 Hz, 1H, 3ax-H), 3.92 (d, J = 3.4 Hz, 1H, 2eq-H), 3.80 (dd, J = 10.6, 10.1 Hz, 1H, 4ax-H), 3.74 
(d, J = 11.0 Hz, 1H, H-7), 3.25 (d, J = 11.0 Hz, 1H, H-7) ppm. 13C NMR (100 MHz, MeOD): δ = 91.0 (6-C), 
78.1 (1-C), 75.4 (4-C), 73.6 (3-C), 72.9 (2-C), 69.9 (5-C), 65.0 (7-C) ppm.  
 
(1R,2R,3R,4S,5S,6S)-1-hydroxymethyl-6-nitrocyclohexane-1,2,3,4,5-pentol 15:   25D – 18 (c = 1.05, CH3OH). 
1H NMR (400 MHz, MeOD): δ = 4.82 (d, J = 10.0 Hz, 1H, 6ax-H), 4.55 (dd, J = 10.0, 3.1 Hz, 1H, 5ax-H), 4.15 
5 
 
(m, 1H, 4eq-H), 4.05 (m, 1H, 3eq-H), 3.85 (d, J = 11.5 Hz, 1H, H-7), 3.72 (d, J = 2.3 Hz, 1H, 2ax-H), 3.25 (d, J 
= 11.5 Hz, 1H, H-7) ppm. 13C NMR (100 MHz, MeOD): δ = 91.5 (6-C), 78.0 (1-C), 76.3 (4-C), 75.4 (2-C), 68.2 
(5-C), 65.9 (3-C), 60.3 (7-C) ppm.  
 
3. Results and discussion 
 
The aim of this project was to develop a green methodology enabling the preparation of a variety of 
nitrocyclitols, controlling the stereochemistry of the asymmetric centers created. Thus we investigated a 
chemoenzymatic pathway where a spontaneous Henry reaction was flanked by two enzymatic reactions 
catalyzed first by an aldolase and then by a phosphatase for the final dephosphorylation step (scheme 2). 
Stereocontrol of C2 and C3 of the nitrocyclitols thus obtained was ensured by an aldolase whereas the one for C1 
and C6 was achieved by the Henry reaction. The stereochemistry of C4 and C5 was already defined during the 
synthesis of nitroaldehydes. Due to the stereoselectivity of each aldolase we would expect the major formation of 
(2R,3R) “D-threo” from FucA or (2R,3S) “L-erythro” from RhuA configurations for the nitrocyclitol. For 
achieving this process we first considered enzyme production and then donor and acceptor aldolases substrates 
syntheses. 
  
Scheme 2: general one-pot multi-steps strategy for the stereocontrol of the asymmetric centers during the 
preparation of nitrocyclitols. Stereocontrol code,  square: aldolases, circle: intramolecular nitroaldolisation, 
ellipse: asymmetric synthesis.  
 
3.1. Syntheses of the substrates for aldolase-mediated reactions. 
 
The DHAP donor substrate was prepared in a straightforward bi-enzymatic phosphorylation system of 
DHA as already described.[35] The phosphate donor (ATP) was regenerated using AK with acetylphosphate. 
Another efficient ATP regeneration system based on pyruvate kinase/phosphoenol pyruvate mixture might also 
be used without any decrease in performance of DHAP preparation as demonstrated by our group for the 
preparation of phosphorylated sugars.[36]  
For preparing the six-members ring nitrocyclitols, linear -nitrobutanal acceptor substrates were synthesized as 
already described,[20, 28, 30] except 4-nitrobutanal for which we have simplified the protocol. Thus the drastic 
procedure using KF as a base at -35°C in methanol[29] was replaced by the use of bovine serum albumin (BSA) 
as base in water at room temperature[37] giving similar yields. A total of four nitrobutanals were systematically 
used with RhuA and FucA (scheme 4 and table 1): 4-nitrobutanal 1 (R1=R2=H), (±)-3-hydroxy-4-nitrobutanal 4 
(R1=H, R2=OH), (2R)-2,3-dihydroxy-4-nitrobutanal 8 (R1=OH, R2=OH) and (2S)-2,3-dihydroxy-4-nitrobutanal 
12 (R1=OH, R2=OH). 
 
3.2. Enzyme productions and development of a rapid indirect activity assay. 
 
6-Histidine tagged RhuA and FucA were overexpressed in E. coli and purified by IMAC using an 
imidazole gradient for elution. Imidazole was then removed by dialysis or ultrafiltration giving fair yields of 
each enzyme after freeze-drying (36 U, 171 mg of FucA; 30 U, 252 mg of RhuA per liter of each culture). Up to 
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now aldolases activity were spectrophotometrically measured at 340 nm using the retro-aldol reaction from their 
natural substrate (L-fuculose-1-phosphate or L-rhamnulose-1-phosphate, scheme 3a). However the 
phosphorylated monosaccharides used to measure these activities are not commercially available which means 
that their syntheses by coupling L-lactaldehyde to DHAP [38, 39] or following other methods described in the 
literature[40, 41] were necessary. An additional problem was the non-availability on the market of L-
lactaldehyde acceptor substrate, thus requiring its preparation following described procedures.[42-44] Due to 
those major disadvantages, we decided to develop another assay for both aldolases involving a cheap (achiral) 
and easily available substrate. Several commercially available aldehydes (ethanal, propanal, isobutyraldehyde, 
benzyloxyacetaldehyde, etc.) were screened and the DHAP conversion level was measured. 
Dimethoxyacetaldehyde (DMA) was found as good substrate as L-lactaldehyde, leading to  more than 95% of 
DHAP consumed compared to 95% with natural acceptor. In parallel the aldol produced was followed applying a 
protocole published by Sheldon’s group.[45] Similar results were obtained when comparing L-lactaldehyde and 
DMA as 94% of aldol was assayed in both cases. Therefore we used DMA to perform the activity assay, more 
suitable for a rapid evaluation of activities in routine production of enzymes (scheme 3b). An indirect assay was 
implemented thereby NADH consumption was followed upon time on aliquots of the biocatalysed aldolisation 
reaction between DMA and DHAP in initial rate conditions. In order to compare with the initial assay[34] and 
taking into account that indirect assays are less accurate, the same batch of a given aldolase was tested. Thus we 
have found a FucA specific activity of 0.21±0.01 U/mg using the retroaldolisation assay and 0.24±0.04 U/mg in 
the aldol way. Proceeding similarly, we have found 0.12±0.01 U/mg for RhuA using the direct assay whereas a 
value of 0.16±0.04 was obtained with the indirect assay. In conclusion, this method could simplify the 
quantification of catalytic activity assay and has given an acceptable order of magnitude for routine production 
of aldolases. 
 
Scheme 3: development of a spectrophotometric activity assay for L-rhamnulose-1-phosphate and L-fuculose-1-
phosphate aldolases. 
 
DHAK was produced and purified as already described by Sánchez-Moreno et al.[33] 
 
3.3. Biocatalysed cascade aldol reactions towards nitrocyclitols. 
 
3.3.1. Implementation	of	the	reactions.	
The first aldehyde involved with DHAP in the cascade process was 4-nitrobutanal 1. This compound being 
water insoluble, DMSO was used as co-solvent. DMSO was generally tolerated by most of the DHAP aldolases 
and up to 50% was accepted for RhuA or 30% for FucA.[39, 46] In our case, a 10% v/v proportion of DMSO in 
water was sufficient for dissolution of the nitroaldehyde. 
Then a first attempt was done to couple DHAK-catalyzed synthesis of DHAP from DHA and RhuA or 
FucA-catalysed aldolisation with nitrobutanal 1 in a one-pot one-step process. At an analytical level DHA 
disappearance was spectrophotometrically monitored using DHAK and GPDH/TPI coupled enzymes with 
NADH. However no DHA consumption was detected, reflecting inhibition of at least one of the kinases 
involved. Further investigations showed that DMSO was responsible for this inhibition on DHAK (a slighter 
inhibition due to the nitroaldehyde was also detected). Those initial assays guided us to focus on a one-pot multi-
steps process where DHAP was allowed to accumulate and then an aldehyde solution in DMSO was added 
followed by the aldolase (scheme 4). As a remark, reactions between nitrobutanals and DHA in borate buffer 
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catalyzed by RhuA have been envisaged following described procedures,[11] unfortunately these attempts stayed 
unsuccessful.  
 
Scheme 4: one-pot three-steps multi-enzymatic process enabling nitrocyclitol 2 and 3 formation. 
At a preparative scale the common compound of both successive reactions of the process was assayed to 
know when each reaction was complete. Thereby DHAP appearance upon DHAK-catalyzed first step was 
monitored till a maximum was reached. Then after addition of the other biocatalyst and reactant, its 
concentration decrease was evaluated upon aldolase-catalyzed step until complete disappearance. At this step, 
without any isolation of the nitrocyclitol phosphate a fourth enzyme was added to the reaction mixture in order 
to hydrolyze the phosphate group. Acid phosphatase (Pase) from wheat germ (E.C. 3.1.3.2) was chosen for its 
large activity spectrum and its low cost. The pH of the reaction mixture was lowered around 5 before adding the 
hydrolase. As the enzymes (DHAK, AK and aldolase) present in the reaction mixture precipitated, the 
suspension was centrifuged. The supernatant was stirred overnight in the presence of Pase. With each aldolase, 
the same two nitrocyclitols 2 and 3 were isolated in good overall yields and separated after flash silica gel 
chromatography. However the ratio determined from chemical yields were quite different, RhuA has provided 
the expected 2R,3S configuration as major one whereas for FucA the 2R,3R configuration was present in minor 
proportion (only 20%). This lack of stereoselectivity could be due to steric hindrance considerations between the 
side chain of the aldehyde and the C-terminal part of the protein as already mentioned.[47] Another reason could 
be the lack of the hydrogen bond naturally occurring between the hydroxyl group in the second position of L-lact 
and a Tyr113 residue within the active site.[47] 
 
The study was pursued with other nitroaldehydes hydroxylated in position 3 and in position 2 and 3 (4, 8 
and 12; Table 1). Even though the acceptor substrate was water soluble like dihydroxynitrobutanal 8 or 12, the 
second strategy was adopted to prevent DHAK inhibition noted in the presence of the nitroaldehydes. Following 
the one-pot multi-steps process, aldehydes 1, 4, 8 and 12 were successfully converted to give the corresponding 
nitrocyclitols in respectively 81, 80, 79 and 82% total yields using RhuA, and 83, 82, 83 and 78% with FucA for 
the overall four reactions. The results are presented in detail table 1. Each nitrocyclitol was purified by silica gel 
flash chromatography and characterized by several NMR experiments (in particular NOESY and coupling 
constants of the chair conformation) referring to the (R) configuration of C2 of the nitrocyclitol provided by any 
aldolase. Even though all aldehydes gave a diastereomeric mixture of nitrocyclitols, they could all be separated 
from each other by chromatography. 
The stereoselectivities shown by the aldolases were different in the presence of the hydroxylated aldehydes 
4, 8 and 12. In table 1, refereeing to these stereoselectivities, under all cyclitol structures the status “expected” 
(noted ex) and “not expected” (noted not ex) was specified. From racemic aldehyde 4 and RhuA as biocatalyst, 
two diastereomers 5 (2R,3S) and 6 (2R,3R) were isolated in 67 and 13 % yield respectively. From 8 and 12, 
samely RhuA has furnished two diastereoisomers in each case: 9 and 10 in 62 and 17 % yields respectively and 
13 and 14 in both 41 % yields. Thus, in addition to the expected 2R,3S cyclitols RhuA has always catalyzed the 
 
8 
 
formation of the “not expected”  2R,3R cyclitols being less and less stereoselective from 4 to 12. Even in the 
presence of a (2S) hydroxyl group (12) like found in the natural substrate this enzyme showed no better 
diastereoselectivity. A rational explanation is that the reaction was under thermodynamic control with total 
consumption of DHAP. Thus kinetic discrimination could not be observed as reported by Fessner’s group.[48] In 
addition, the diastereoselectivity seems highly substrate-dependent as such low selectivity was also observed by 
Clapés and coll.[47] 
On the contrary, FucA has always catalyzed the formation of the expected 2R,3R stereocentres from 
aldehydes 4, 8 and 12., Two cyclitols were formed from each aldehyde, 6 and 7 in 58 and 24 % yields, 10 and 11 
in 39 and 44 % yields and finally 14 and 15 in 44 and 34 % yields respectively. Thus FucA has been highly 
stereoselective in presence of hydroxylated aldehydes. It might be explained by the hydroxyl group(s) restoring 
probably a good positioning of the substrate in the active site due to hydrogen bonds.[47]  
 
Table 1: Nitrocyclitols stereoisomers prepared following the one-pot two-steps cascade reactions 
 
 
We would like then to focus on the Henry reaction. For a better visualization the nitrocyclitol 
configurations and conformations deduced from NMR analyses are also proposed in table 2. From aldehyde 1, 
considering the expected defined configuration by the aldolase (R,S for RhuA or R,R for FucA), one major 
nitrocyclitol (2 or 3) has been obtained. Thus this cyclisation has been highly stereoselective. In the other cases, 
the substrates 4, 8 and 12 are bearing a hydroxyl group in β to the nitro group (C3 on the aldehyde, becoming C5 
on the cyclitol). Due to the existence of both R and S configurations on this position C3, two main families of 
nitrocyclitols have been obtained with the same relative configurations: hydroxymethyl on C1 and –NO2 on C6 
trans relatives as well as the hydroxyl on C5 and –NO2 on C6. In table 2, these substituants can be clearly seen 
always in equatorial positions however with the chair conformation inverted. 5 and 6 from RhuA or 6 and 7 from 
FucA could be cited as example. All these results are consistent with those obtained in our previous work 
illustrated scheme 1. They were evidently expected with R,S stereoselective RhuA as all the process could lead 
to the enantiomers of cyclitols prepared from FSA or FBA. When the multistep process was performed with 
FucA, the first stereocentres created on the aldols were R,R. Modification of these configurations when 
compared with FSA or RhuA case has not influenced the cyclisation as comparable results were obtained. The 
Henry cyclisation has led to the same two families whatever the first created C-C bond stereochemistry was. In 
conclusion the spontaneous Henry reaction was also highly stereoselective when additional hydroxyl groups on 
the aldehydes were present. 
Each multistep process has provided two cyclitols on which C5 is R or S. However, it should be pointed out 
that the ratio around 70/30 for cyclitols 6 and 7 taken as example is particularly far from an expected 50/50 value 
considering the racemic aldehyde 4. This can only be explained by a two-fold retro-Henry reaction illustrated 
Aldehyde Nitrocyclitol*  Isolated yield %  Aldolase Ratio# 
 
1 ex RhuA 
not ex FucA 
 
not ex RhuA 
ex FucA 
 
  
2/3 77/4 RhuA 
2/3 66/17 FucA 
 
95/5 
80/20 
 
4 
ex RhuA 
 
not ex RhuA 
ex FucA 
 
 ex FucA 
 
 
 
5/6 67/13 RhuA 
6/7 58/24 FucA 
 
 
84/16 
71/29 
(2R)-8 
 ex RhuA 
 
not ex RhuA 
ex FucA 
ex FucA 
 
 
9/10 62/17 RhuA 
10/11 39/44 FucA 
 
 
79/21 
47/53 
 
(2S)-12 
ex RhuA not ex RhuA ex FucA 
ex FucA 
 
 
13/14 41/41 RhuA 
14/15 44/34 FucA 
 
 
50/50 
57/43 
For aldehyde 4, 8 and 12 preparations see references [28, 30]; * nitrocyclitols 2, 5, 9 and 13 are enantiomers of those prepared with 
FBA or FSA[28]; # calculated from chemical yields; ex: expected; not ex: not expected.
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scheme 5.[20] As we discussed in previous publications,[20, 28] under smooth heating during water removal or 
at a slight alkaline pH, whatever the C3 configuration of the acceptor aldehyde is, cyclitols 5 to 15 could undergo 
a retro-Henry reaction. This reversibility has led to a partial enrichment (or total in case of RhuA governed 
process) of the more stable isomer under thermodynamic control. For example, considering compounds 7 and 15 
in table 2, two hydroxyl groups are clearly in 1,3-diaxial interaction thus disadvantaging these stereoisomers 
when compared with 6 and 14 respectively. This could explain the differences between the 50/50 expected ratio 
and the experimental results. To note, 10 and 11 in around 50/50 ratio are both showing two hydroxyl 
substituants in 1,3-diaxial interaction.  
 
 
Table 2: Nitrocyclitol configurations and conformations 
 
 
4. Conclusions 
We finalized herein a powerful and green one-pot four sequential steps process involving two kinases, an 
aldolase and a phosphatase. It enabled the versatile preparation of several nitrocyclitols in terms of structure and 
stereochemistry, precursors of aminocyclitols as potential glycosidase inhibitors. This methodology exemplified 
the synergy by combining chemical and enzymatic steps and has led to a small library of nitrocyclitols by 
varying only the starting aldehyde and the aldolase. Except with 4-nitrobutanal, FucA was found highly 
stereoselective, much more than RhuA. Even though the products were obtained as mixtures due to lack of 
stereoselectivity by the aldolases or to the presence of racemic alcohol, they were all successfully separated by 
chromatography. The Henry reaction was revealed highly stereoselective, defining two or three stereocenters 
when a hydroxyl was present on the aldehyde. These one-pot cascade processes reinforce the powerful of 
biocatalysis by limiting the protection-deprotection steps mainly encountered in the cyclitol synthesis.  
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